VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+4.29%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$891M
AUM Growth
+$891M
(+688%)
Cap. Flow
+$760M
Cap. Flow
% of AUM
85.31%
Top 10 Holdings %
Top 10 Hldgs %
57.95%
Holding
371
New
107
Increased
50
Reduced
125
Closed
30
Top Buys
| 1 |
EQM
EQM Midstream Partners, LP
EQM
|
$78.1M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$77.3M |
| 3 |
MPLX
MPLX
|
$72.7M |
| 4 |
Marathon Petroleum
MPC
|
$61.2M |
| 5 |
ENLK
EnLink Midstream Partners, LP
ENLK
|
$43.2M |
Top Sells
| 1 |
Incyte
INCY
|
$9.28M |
| 2 |
Vanguard Utilities ETF
VPU
|
$1.69M |
| 3 |
Vanguard Energy ETF
VDE
|
$1.3M |
| 4 |
iShares MSCI India ETF
INDA
|
$1.24M |
| 5 |
Fidelity MSCI Financials Index ETF
FNCL
|
$1.03M |
Sector Composition
| 1 | Energy | 74% |
| 2 | Healthcare | 7.58% |
| 3 | Utilities | 1.27% |
| 4 | Financials | 0.09% |
| 5 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
151
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $415K | 0.04% |
288
-206
| -42% | -$297K |
|
152
Voyager Therapeutics
VYGR
$204M
| $414K | 0.04% |
21,869
-15,633
| -42% | -$296K |
|
|
PRTK
153
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $413K | 0.04% |
42,584
-31,186
| -42% | -$302K |
|
|
ATNX
154
DELISTED
Athenex, Inc. Common Stock
ATNX
| $411K | 0.04% |
1,321
-945
| -42% | -$294K |
|
155
Prothena Corp
PRTA
$452M
| $410K | 0.04% |
31,339
-23,019
| -42% | -$301K |
|
156
Rhythm Pharmaceuticals
RYTM
$6.75B
| $410K | 0.04% |
14,044
-10,330
| -42% | -$302K |
|
|
IMMU
157
DELISTED
Immunomedics Inc
IMMU
| $410K | 0.04% |
19,666
-14,095
| -42% | -$294K |
|
158
Iovance Biotherapeutics
IOVA
$800M
| $406K | 0.04% |
36,120
-25,831
| -42% | -$290K |
|
|
SAGE
159
DELISTED
Sage Therapeutics
SAGE
| $406K | 0.04% |
2,871
-2,052
| -42% | -$290K |
|
160
Arcus Biosciences
RCUS
$1.24B
| $400K | 0.04% |
28,669
-21,065
| -42% | -$294K |
|
|
CBAY
161
DELISTED
Cymabay Therapeutics
CBAY
| $400K | 0.04% |
36,120
-25,831
| -42% | -$286K |
|
|
HEP
162
DELISTED
Holly Energy Partners, L.P.
HEP
| $400K | 0.04% |
+12,709
| New | +$400K |
|
|
ARRY
163
DELISTED
Array Biopharma Inc
ARRY
| $400K | 0.04% |
26,284
-18,803
| -42% | -$286K |
|
164
Pinnacle West Capital
PNW
$10.6B
| $388K | 0.04% |
+4,896
| New | +$388K |
|
165
Alnylam Pharmaceuticals
ALNY
$58.6B
| $387K | 0.04% |
4,427
-3,154
| -42% | -$276K |
|
|
GBT
166
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $382K | 0.04% |
10,053
-7,196
| -42% | -$273K |
|
167
Abeona Therapeutics
ABEO
$356M
| $381K | 0.04% |
1,191
-851
| -42% | -$272K |
|
168
PPL Corp
PPL
$26.8B
| $380K | 0.04% |
+13,000
| New | +$380K |
|
|
FPRX
169
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $373K | 0.04% |
26,824
-19,183
| -42% | -$267K |
|
170
Apellis Pharmaceuticals
APLS
$3.51B
| $372K | 0.04% |
20,895
-15,328
| -42% | -$273K |
|
171
Akebia Therapeutics
AKBA
$827M
| $371K | 0.04% |
42,037
-30,371
| -42% | -$268K |
|
172
Southwest Gas
SWX
$5.71B
| $370K | 0.04% |
+4,680
| New | +$370K |
|
|
AGEN
173
Agenus
AGEN
$136M
| $360K | 0.04% |
8,560
-6,156
| -42% | -$259K |
|
174
Alaunos Therapeutics
TCRT
$4.51M
| $355K | 0.04% |
739
-528
| -42% | -$254K |
|
|
BLUE
175
DELISTED
bluebird bio
BLUE
| $352K | 0.04% |
186
-132
| -42% | -$250K |
|